Sort
172,184 grants matching “inflammation”
Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI
$841,318Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI
$841,318Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HL
Biochemical and Genetic Markers of Type 2 Diabetes Risk
$841,303Frank B Hu · Brigham And Women'S Hospital · R01 · FY2010 · DK
Inflammatory molecules in radiation risk assessment
$841,241University Of Rochester · U19 · FY2005 · AI
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$841,182Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2022 · NS
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$841,127John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$841,127John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
MICRORNAS IN CIRCULATION: ONTOLOGIES OF ASTHMA SEVERITY AND TREATMENT (MICROCOAST)
$841,049Kelan G Tantisira · Brigham And Women'S Hospital · R01 · FY2017 · HL
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$841,023Charles T Roberts · Oregon Health & Science University · R01 · FY2021 · DK
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADULTHOOD
$840,995University Of Arizona · R01 · FY2003 · HL
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme
$840,956Kevin Xu · Bexion Pharmaceuticals, Inc. · R44 · FY2011 · CA
Longitudinal Analysis of Transcriptomic Endophenotypes in Asthma
$840,882Geoffrey L Chupp · Yale University · R01 · FY2015 · HL
UAB Multidisciplinary Clinical Research Center
$840,879S Louis Bridges · University Of Alabama At Birmingham · P60 · FY2013 · AR
Shear stress Regulation of Endothelial Glycolysis via METTL3-mediated RNA m6A Modification
$840,873John Y-J Shyy · University Of California, San Diego · R01 · FY2024 · HL
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$840,829Suman Srinivasa · Massachusetts General Hospital · R01 · FY2024 · HL
Characterization of protective roles of ApoE2 against aging and Alzheimer's disease
$840,770Dongming Cai · Icahn School Of Medicine At Mount Sinai · R56 · FY2019 · AG
Genetics of Asthma and COPD
$840,750Steven D Shapiro · Brigham And Women'S Hospital · P01 · FY2010 · HL
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$840,721Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2020 · AI
Control Systems Governing Short vs Longterm Humoral & Cellular Immunity
$840,715Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2016 · AI
Determinants of insufficient sleep among blacks and effects on disparities in health outcomes
$840,599Girardin Jean-Louis · New York University School Of Medicine · R01 · FY2019 · HL
Sleep Patterns as a risk factor for disease in the Hispanic Community Health Stud
$840,434Sanjay R Patel · Brigham And Women'S Hospital · R01 · FY2011 · HL
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
$840,301Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2017 · HL
3BNC117 mAb in HIV-infected subjects on combination ART
$840,281Marina Caskey · Rockefeller University · U01 · FY2015 · AI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics
$840,191Ann Marie Schmidt · New York University School Of Medicine · R24 · FY2014 · DK
Aging and Fracture Risk among HIV-infected and HIV-uninfected Men
$840,190Todd T Brown · Johns Hopkins University · R01 · FY2011 · AI